This white paper describes process modeling and compares the process economics of a conventional upstream process versus three perfused seed train alternatives in combination with either a conventional fed-batch or high-seed fed-batch bioreactor.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A Cost Analysis and Evaluation of Perfused Seed Train Scenarios Through Process Modeling
Related Resources
Monitoring SARS-CoV-2 interaction with ACE2
In this technical note, we investigate the interactions between the following: The spike glycoprotein binding with ACE2, Spike glycoprotein and anti-spike antibodies (mAb/ pAb), The spike glycoprotein binding with mAb/pAb to inhibit the interaction with ACE2
Accelerating Cell Line and Process Development
Development of a high-producing cell line supported by a robust upstream process are critical early steps in the production of monoclonal antibodies (mAbs). Optimization of this upstream workflow is essential to deliver a sufficiently high titer to...
Supplier Info Centre
For more product information visit Take the Right Path Upstream with MilliporeSigma.